Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_assertion type Assertion NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_head.
- NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_assertion description "[Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_provenance.
- NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_assertion evidence source_evidence_literature NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_provenance.
- NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_assertion SIO_000772 25327479 NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_provenance.
- NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_assertion wasDerivedFrom befree-2016 NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_provenance.
- NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_assertion wasGeneratedBy ECO_0000203 NP1230536.RAcbNZcub0uJksZHTFwyN-umEBu2C1sQXCWsjM4JvqJr4130_provenance.